3P - Post Doc Seminar - 26 October

This month's 3P Seminar features Jack Humphrey, Postdoc Fellow at Mount Sinai School of Medicine, discussing 'Integrating genetic and transcriptomic data from ALS patients across multiple brain tissues'

Latest

Scotland's Virtual Kiltwalk

Join Scotland’s ‘virtual’ Kiltwalk challenge from the 23 – 25 April in support of The Cure Parkinson’s Trust (CPT).
Raid Local 2021: Ventoux Local

Join us on the 16th May for Raid Local 2021: Ventoux Local. Inspired by the infamous Club des Cinglés challenge to climb Mont Ventoux using 3 different routes in one day, riders will be training, planning and mapping to cover the equivalent distance and vertical ascent of 1, 2 or all 3 of those epic routes, all in one day, all on their local roads.
Webinar - Coronavirus and Parkinson's

Rewatch - Listen to stimulating discussions around recent publications on Coronavirus and Parkinson’s.
The AZA-PD study: a clinical trial of azathioprine in Parkinson's

A research group in Cambridge - supported by The Cure Parkinson's Trust and Cambridge Centre for Parkinson-Plus - will be conducting a clinical trial to test whether suppressing the immune system can help to slow the progression of Parkinson's.

3P - Post Doc Seminar - September

In this latest 3P seminar, Mary Herrick, from the LaVoie lab at the University of Florida, Emmanuel Quansah, from the Brundin lab at Van Andel Institute and Ruwani Wijeyekoon from the Barker/Williams-Gray lab at the University of Cambridge discuss 'Where and how does Parkinson's start?'
3P - Post Doc Seminar - 27 August

Re-watch this 3P seminar: Roshni Patel, Michelle Tosi and Gian Pal discuss clinical rating scale development and the topic of Parkinson's and DBS: cognitive effects in GBA mutation carriers.
3P - Post Doc Seminar - 25 August

Re-watch: In this 3P seminar Ben Stecher and Hugh Johnson discuss their ideals for a neuromodulation clinic focused on physical activities that benefit PwP.
3P - Post Doc Seminar - 30 July

(Awaiting permissions) William Hancock-Cerutti, MD-PhD candidate at Yale University and Chantelle Evans, postdoc at University of Pennsylvania, and Louisa Wang, postdoc at University of Toronto present on “Cell Biology and Neurodegeneration”..
3P - Post Doc Seminar - 25 June

Re-watch: Willemieke Kouwenhoven presents on 'Vglut2 expression in dopamine neurons contributes to post-lesional striatal reinnervation' and Benoît Delignat-Lavaud discusses 'Mechanisms of somatodendric dopamine release and its contributions to post-lesional plasticity in a PD model”.
3P - Post Doc Seminar - 23 June

Re-watch: Malu G. Tansey, Professor at the University of Florida, and Anita Corbett, Professor at Emory University, presents on “Crucial Conversations and Self-Awareness – Overcoming Impostor Syndrome and Stereotype Threat in Academia.”
3P - Post Doc Seminar - 28 May

Re-watch: Miguel Aguileta, Postdoc at Van Andel Institute, presenting 'Huntintin (HTT) aggregates trigger an immune response' and Thomas Karikari, University of Gothenburg, discussing 'Blood phosphorylated-tau as Alzheimer’s disease diagnostic markers'.
3P - Post Doc Seminar - 21 May

Re-watch our 'Olfaction in Parkinson’s disease' themed session: Michaela Johnson, presents on 'Deficits in olfactory sensitivity in a mouse model of Parkinson’s disease' and Aishwarya Kulkarni discusses 'α-Synuclein perturbs in vivo neural activity following seeding in the olfactory bulb'.
3P - Post Doc Seminar - 14 May

Re-watch: Our 'Multiple system atrophy (MSA)' themed session, as Raphaella So presents on 'Studying alpha-synuclein diseases in the context of conformational strains”'' and MSA patient advocate Beverly K. Wilson, discusses 'Extraordinarily Healthy! . . . except for MSA'.
3P - Post Doc Seminar - 7 May

Re-watch: Sound career advice from Dr Malú Tansey, Prof. of Department of Neuroscience, Director for Translation Research in Neurodegenerative Disease, University of Florida, Dr Laura Volpicelli-Daley Assistant Prof. The University of Alabama, Birmingham and Dr Michael Henderson Assistant Prof. Van Andel Institute.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

The Science of Parkinson's - Dr Simon Stott, Deputy Director of Research

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more